Joachim Kohn, PhD Named as a Fellow of the National Academy of Inventors

Share Article

The National Academy of Inventors has named Dr. Joachim Kohn, PhD, the Director of the New Jersey Center for Biomaterials at Rutgers University, as a Fellow of the Academy in recognition to his contributions to biomaterials and regenerative medicine.

The National Academy of Inventors has named Rutgers University Board of Governors Professor and Director of the New Jersey Center for Biomaterials, Dr. Joachim Kohn, PhD, as a fellow of the National Academy of Inventors.

Joachim Kohn, PhD, is a research entrepreneur, a multi-disciplinary translational scientist, and a national leader in the development of new biomaterials for medical applications and drug delivery. In 1997, Kohn founded the New Jersey Center for Biomaterials, which has grown into a collaborative network spanning 25 institutions and 40 laboratories. As a translational scientist, Kohn has 54 issued US Patents on novel biomaterials and seven companies have licensed his technologies. He has raised about $100M in research funding at Rutgers and helped four licensees to raised over $200M in private capital. He is mostly known for his seminal work on "pseudo-poly(amino acid)s"- a new class of polymers that combine the non-toxicity of individual amino acids with the strength and processability of high-quality engineering plastics. Medical devices using these materials have been implanted in more than 40,000 patients.

The National Academy of Inventors, which was founded three years ago, announced its 2013 fellows on Dec. 10. They include 143 inventors who collectively hold more than 5,600 U.S. Patents. Among them are 69 members of the National Academies, six recipients of the U.S. National Medal of Technology and Innovation, and nine Nobel Laureates.

The New Jersey Center for Biomaterials (NJCBM) was founded in 1997. Based at Rutgers, the State University of New Jersey, the center spans academia, industry and government. Staffed by biomaterial scientists, the Center works toward the goal to improve health care and quality of life by developing advanced biomedical products for tissue repair and replacement as well as the delivery of pharmaceutical agents. The Center’s technologies have been translated into clinical and pre-clinical products including surgical meshes, cardiovascular stents, bone regeneration scaffolds, and ocular drug delivery systems.

Media Contact:

Louli Kourkounakis
(732) 445 0488 ext. 40002

Share article on social media or email:

View article via:

Pdf Print

Contact Author

John Bushby

+1 (732) 445-6624
Email >
Visit website